MetaCap

PACS Group Inc. (PACS)

NYSE: PACSHealth CareHospital/Nursing ManagementUSD

43.67+0.64 (+1.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PACS stock chart

Technical analysis

Key statistics

All statistics
52-week range
27.37 – 51.68
Day range
42.84 – 44.36
Volume / Avg
964.37K / 809.18K
Beta
—

52-week range

$27.37$51.68

PACS stock today

PACS Group (PACS) closed at $43.67 on Nov 20, up 1.49% (+$0.64), versus the S&P 500's 3.70% decline. Shares are 15.5% below their 52-week high of $51.68, set on Nov 4, 2026 and 59.6% above the 52-week low of $27.37, in the middle of the past year's range. PACS is up 13.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 58.8%.

At 24.8x trailing earnings, PACS Group trades above the peer-group median of 16.6x. Its forward P/E of 15.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About PACS Group

Company profile

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties.

Industry
Hospital/Nursing Management
CEO
Mr. Jason Murray
Headquarters
Salt Lake City, UT
Employees
47,455
IPO year
2024
Website
pacs.com

Financial highlights

Full financials

In fiscal 2025, PACS Group generated $5.29 billion in revenue, up 29.3% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $191.5 million (+243.5% year over year), for a net margin of 3.6% versus a median of 3.6% in the prior 3 years. Gross margin was 21.9% (up from 19.4%) and operating margin 5.9%.

PACS Group annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$5.29B$4.09B$3.11B$2.42B
Growth+29.32%+31.44%+28.47%—
Net income$191.54M$55.76M$112.87M$150.50M
EPS (diluted)$1.22$0.38$0.88$1.17

Analyst forecast

Forecast

Consensus (6 analysts)

strong_buy

Avg. price target

$62.50+43.12%

  • Strong buy 2
  • Buy 4
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $57.00High $67.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$0.37 vs $0.56
Surprise
-33.93%

PACS news

All PACS news

PACS Group peers

Health Care sector
PACS peer companies
CompanyPrice% ChgMarket capCompare
SGRYSurgery Partners Inc.26.78+0.34%$3.50Bvs PACS
ENSGThe Ensign Group Inc.176.32-0.15%$10.29Bvs PACS
UHSUniversal Health Services Inc.179.43+2.54%$10.34Bvs PACS
NHCNational HealthCare Corporation190.77+1.18%$2.99Bvs PACS
MDPediatrix Medical Group Inc.30.22+0.94%$2.36Bvs PACS
BKDBrookdale Senior Living Inc.8.86+1.96%$2.12Bvs PACS
ARDTArdent Health Inc.15.08+4.00%$2.10Bvs PACS
HCSGHealthcare Services Group Inc.24.72-0.20%$1.67Bvs PACS

Indexes, lists and sector

PACS Group stock FAQ

What is PACS Group's stock price today?

PACS last traded at $43.67 as of Nov 20, 4:00 PM EST, up 1.49% on the day. Prices are delayed at least 15 minutes.

What is PACS's P/E ratio?

PACS trades at a trailing P/E ratio of 24.81 and a forward P/E of 15.30, compared with a median of 16.6 for its closest peers.

Who is PACS Group's CEO?

Mr. Jason Murray is the chief executive officer of PACS Group Inc., which has about 47,455 employees.

What is the PACS 52-week high?

The 52-week high for PACS is $51.68 and the 52-week low is $27.37. The stock is currently 15.5% below its high.

Compare PACS